HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

University of Michigan researchers have uncovered new details of the process that HIV uses to hijack cells' transportation ...

Infections by measles virus and by HIV cause a state of immunodeficiency in the host. While measles virus leads to a transient immunodeficiency with depression of cellular mediated immunity ...

Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV.

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections. Originally approved in 2012 as a treatment for people with HIV that no longer responded to ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

A second study reported the twice-a-year injections lowered the HIV infection rate by 96% in groups of cisgender men and gender-diverse people in the U.S., Argentina, Brazil, Mexico, Peru, South ...

He however expressed his concern over the new infections among those aged between 15-24 years, noting that this spelt doom for the country in the coming years. “We have seen an increase in new ...

People have to test negative for HIV before they can receive the shot, which is administered under the skin of the abdomen. There are an estimated 30,000 new HIV infections in the U.S. annually.